Concepedia

IsoPlexis (United States)

I(

Statistics

Publications

93

Citations

15.1K

Authors

15

Location

Branford, United States

IsoPlexis (United States) is a company institution in Branford, United States known for immunology, life sciences, and oncology.

HomepageROR

Top concepts

Publications

93

Multiple early factors anticipate post-acute COVID-19 sequelae

Yapeng Su, Dan Yuan, Daniel Chen et al. · Cell · 2022 · 1.2K citations · Full text

, , +16

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su, Daniel Chen, Dan Yuan et al. · Cell · 2020 · 640 citations · Full text

, , +17

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 572 citations · Full text

, , +17

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Peter A. Szabo, Pranay Dogra, Joshua I. Gray et al. · Immunity · 2021 · 392 citations · Full text

, , +17

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

John M. Rossi, Patrick Paczkowski, Yueh-wei Shen et al. · Blood · 2018 · 340 citations · Full text

, , +12

1–5 of 93

Authors

15

  1. JZ
    Jing Zhou

    IsoPlexis (United States), United States

    154 publications · 6.3K citations

    30

    h-index

  2. SM
    Sean Mackay

    IsoPlexis (United States), United States

    215 publications · 6.2K citations

    30

    h-index

  3. PP
    Patrick Paczkowski

    IsoPlexis (United States), United States

    21 publications · 820 citations

    11

    h-index

  4. CN
    Colin Ng

    IsoPlexis (United States), United States

    31 publications · 959 citations

    11

    h-index

  5. BF
    Brianna Flynn

    IsoPlexis (United States), United States

    62 publications · 418 citations

    6

    h-index

1–5 of 15